March 27 (Reuters) - Phaserx Inc PZRX.O
* PhaseRx reports fourth quarter and full year 2016
financial results and provides corporate update
* Q4 loss per share $0.30
* As of December 31, 2016, company had cash, cash
equivalents, and marketable securities of $15.5 million
* Believes it has sufficient cash to fund its operations for
at least next 12 months
* In 2017, anticipate completing GLP toxicology and GMP
manufacturing activities and submitting an ind for PRX-OTC in Q4
Source text for Eikon: ID:nPn6yBQ3Ma
Further company coverage: PZRX.O
((Bangalore.newsroom@thomsonreuters.com;))